MEAGAN CONWELL: Open Payments
NPI 1164156980 · BLOOMSDALE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 35 payments from 15 companies in 2025. Trend: 2023 $28 · 2024 $380 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $217 |
| Lundbeck LLC | 3 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $26 |
| Biogen, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
Products named: VRAYLAR, REXULTI, SPRAVATO, AUSTEDO XR, FANAPT, LOREEV XR, Qelbree, ZURZUVAE.
Industry payments across MO — which companies pay providers there.
